United States Infectious Diseases Treatment Market Trends: Key Players, Innovations, and Future Outlook 2025 | Pfizer Inc., AbbVie, Gilead Sciences, Inc.

Market Size and Growth:

The Global Infectious Diseases Treatment Market size reached US$ 189.09 Billion in 2024 from US$ 182.65 Billion in 2023 and is expected to reach US$ 264.75 Billion by 2033, growing at a CAGR of 3.9% during the forecast period 2025-2033.

The Infectious Diseases Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/infectious-diseases-treatment-market?sz

The Infectious Diseases Treatment Market encompasses the development, production, and commercialization of drugs, therapies, and vaccines aimed at preventing, managing, and curing infectious diseases caused by bacteria, viruses, fungi, and parasites. It includes antiviral, antibacterial, antifungal, and antiparasitic treatments, catering to hospitals, clinics, and research institutions, driven by rising disease prevalence, technological advancements, and increasing healthcare awareness globally.

Recent Key Developments of United States (U.S):

Sept 2025: Experts from major infectious disease and cancer research centers called for a new clinical trials network focused on developing and testing therapies for immunocompromised patients, a group often excluded from trials.

Sept 2025: A partnership was announced between the Gates Foundation and an Indian manufacturer to produce a low-cost, generic version of lenacapavir for HIV prevention in low- and middle-income countries. This builds on the FDA's June 2025 approval of the drug for twice-yearly injections.

Aug 2025: The FDA approved Brinsupri (brensocatib) for the treatment of non-cystic fibrosis bronchiectasis.

July 2025: The FDA granted approval for Ekterly (sebetralstat) to treat acute hereditary angioedema attacks.

June 2025: The FDA approved Enflonsia (clesrovimab-cfor) to prevent respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants.

List of the Key Players in the Infectious Diseases Treatment Market:

Pfizer Inc.
AbbVie
Gilead Sciences, Inc.
Merck & Co., Inc.
Sandoz Group AG
B. Braun SE
Bayer AG
AstraZeneca
Novartis AG.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=infectious-diseases-treatment-market

Segments Covered in the Infectious Diseases Treatment Market:

By Infection Type: Viral Infections, Bacterial Infections, Fungal Infections, and Parasitic Infections.

By Drug Class: Antibacterials, Antivirals, Antifungals, Antiparasitic Drugs, and Others.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/infectious-diseases-treatment-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Infectious Diseases Treatment market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Infectious Diseases Treatment Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Infectious Diseases Treatment market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Infectious Diseases Treatment Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Infectious Diseases Treatment Market in 2025?
◆ What is the projected growth rate of the Infectious Diseases Treatment Market through 2033?
◆ Who are the key players in the Infectious Diseases Treatment Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.